Current and emerging biologic therapies for allergic rhinitis and chronic rhinosinusitis
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - February 19, 2020 Category: Drugs & Pharmacology Authors: Amelia Licari Riccardo Castagnoli Maria De Filippo Thomas Foiadelli Maria Angela Tosca Gian Luigi Marseglia Giorgio Ciprandi Source Type: research

Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - February 17, 2020 Category: Drugs & Pharmacology Authors: G. Caldarola F. Pirro A. Di Stefani M. Talamonti M. Galluzzo S. D ’Adamio M. Magnano N. Bernardini P. Malagoli F. Bardazzi C. Potenza L. Bianchi K. Peris C. De Simone Source Type: research

CAR T cells and checkpoint inhibition for the treatment of glioblastoma
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - February 17, 2020 Category: Drugs & Pharmacology Authors: Steven H. Shen Karolina Woroniecka Andrew B. Barbour Peter E. Fecci Luis Sanchez-Perez John H. Sampson Source Type: research

Ravulizumab for the treatment of paroxysmal nocturnal hemoglobinuria
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - February 14, 2020 Category: Drugs & Pharmacology Authors: Jong Wook Lee Austin G Kulasekararaj Source Type: research

Autologous activated platelet-rich plasma (AA-PRP) and non-activated (A-PRP) in hair growth: a retrospective, blinded, randomized evaluation in androgenetic alopecia
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - February 14, 2020 Category: Drugs & Pharmacology Authors: Pietro Gentile Simone Garcovich Source Type: research

Clinical development on the frontier: gene therapy for duchenne muscular dystrophy
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - February 13, 2020 Category: Drugs & Pharmacology Authors: Damon R. Asher Khampaseuth Thapa Sachi D. Dharia Navid Khan Rachael A. Potter Louise R. Rodino-Klapac Jerry R. Mendell Source Type: research

DC-CIK as a widely applicable cancer immunotherapy
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - February 13, 2020 Category: Drugs & Pharmacology Authors: Shuo Wang Xiaoli Wang Xinna Zhou Herbert Kim Lyerly Michael A. Morse Jun Ren Source Type: research

Ultra-low dose rituximab for refractory pemghigus vulgaris: a pilot study
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - February 13, 2020 Category: Drugs & Pharmacology Authors: Irene Russo Serena Miotto Andrea Saponeri Mauro Alaibac Source Type: research

Semliki Forest virus-based immunotherapy for cancer
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - February 13, 2020 Category: Drugs & Pharmacology Authors: Kenneth Lundstrom Source Type: research

Positioning ustekinumab in moderate-to-severe ulcerative colitis: new kid on the block
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - February 13, 2020 Category: Drugs & Pharmacology Authors: Gionata Fiorino Mariangela Allocca Carmen Correale Giulia Roda Federica Furfaro Laura Loy Alessandra Zilli Laurent Peyrin-Biroulet Silvio Danese Source Type: research

Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving Nivolumab
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - February 7, 2020 Category: Drugs & Pharmacology Authors: Francesco Pantano Marco Russano Alfredo Berruti Giovanni Mansueto Maria R. Migliorino Vincenzo Adamo Giuseppe Aprile Alain Gelibter Corrado Ficorella Alfredo Falcone Antonio Russo Michele Aieta Michele Maio Olga Martelli Sandro Barni Andrea Napolitano Eli Source Type: research

Will oral semaglutide be used to reduce cardiovascular risk in subjects with type 2 diabetes instead of subcutaneous semaglutide?
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - February 6, 2020 Category: Drugs & Pharmacology Authors: Sheila A. Doggrell Source Type: research

Efficacy of biologics in atopic dermatitis
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - February 4, 2020 Category: Drugs & Pharmacology Authors: Jianni Wu Emma Guttman-Yassky Source Type: research

Pembrolizumab for the treatment of colorectal cancer
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - February 4, 2020 Category: Drugs & Pharmacology Authors: Dahna Coupez Pauline Hulo Yann Touchefeu C éline Bossard Jaafar Bennouna Source Type: research

Epidemiological data and utilization patterns of anti-TNF alpha therapy in the Hungarian ulcerative colitis population between 2012-2016
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - January 29, 2020 Category: Drugs & Pharmacology Authors: P éter Kunovszki Kata Judit Sz ántó Judit Gimesi-Orsz ágh P éter Takács Andr ás Borsi Anita B álint Klaudia Farkas Ágnes Milassin P éter L. Lakatos Tam ás Szamosi Tam ás Molnár Source Type: research

Novel immunotherapy combinations for genitourinary cancers
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - January 28, 2020 Category: Drugs & Pharmacology Authors: Munjid Al Harthy Jason Redman Ravi A. Madan Source Type: research

Is there room for immunomodulators in ulcerative colitis?
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - January 25, 2020 Category: Drugs & Pharmacology Authors: Tarun Chhibba Christopher Ma Source Type: research

Tumor localized agonistic anti-CD40 therapy and beyond
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - January 25, 2020 Category: Drugs & Pharmacology Authors: Mohamed Eltahir Helena Persson Sara Mangsbo Source Type: research

Histological healing: should it be considered as a new outcome for ulcerative colitis?
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - January 25, 2020 Category: Drugs & Pharmacology Authors: Arianna Dal Buono Giulia Roda Marjorie Argollo Laurent Peyrin-Biroulet Silvio Danese Source Type: research

Anti-IL-4/IL-13 for the treatment of asthma: the story so far
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - January 25, 2020 Category: Drugs & Pharmacology Authors: Angela Moran Ian D Pavord Source Type: research

Prospects of biological and synthetic pharmacotherapies for glioblastoma
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - January 25, 2020 Category: Drugs & Pharmacology Authors: David B. Altshuler Padma Kadiyala Felipe J. Nu ñez Fernando M. Nu ñez Stephen Carney Mahmoud S. Alghamri Maria B. Garcia-Fabiani Antonela S. Asad Alejandro J. Nicola Candia Marianela Candolfi Joerg Lahann James J. Moon Anna Schwendeman Pedro R. Lowenste Source Type: research

Vedolizumab and etrolizumab for ulcerative colitis: twins or simple cousins?
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - January 25, 2020 Category: Drugs & Pharmacology Authors: Ferdinando D ’Amico Silvio Danese Laurent Peyrin-Biroulet Source Type: research

Targeting the cutaneous lymphocyte antigen (CLA) in inflammatory and neoplastic skin conditions
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - January 25, 2020 Category: Drugs & Pharmacology Authors: Alvise Sernicola Irene Russo Micol Silic-Benussi Vincenzo Ciminale Mauro Alaibac Source Type: research

Up-to-date surgery for ulcerative colitis in the era of biologics
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - January 25, 2020 Category: Drugs & Pharmacology Authors: Takayuki Yamamoto Michele Carvello Amy Lee Lightner Antonino Spinelli Paulo Gustavo Kotze Source Type: research

Antibody therapies for multiple myeloma
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - January 25, 2020 Category: Drugs & Pharmacology Authors: Ioannis Ntanasis-Stathopoulos Maria Gavriatopoulou Evangelos Terpos Source Type: research

Efficacy of Tumour Necrosis Factor-alpha therapy in paediatric Crohn ’s disease patients with perianal lesions: a systematic review
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - January 25, 2020 Category: Drugs & Pharmacology Authors: Carla Carnovale Anna Maffioli Gloria Zaffaroni Faizan Mazhar Vera Battini Giulia Mosini Marco Pozzi Sonia Radice Emilio Clementi Piergiorgio Danelli Source Type: research

Bioengineering strategies for nephrologists: kidney was not built in a day
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - January 25, 2020 Category: Drugs & Pharmacology Authors: Anna Julie Peired Benedetta Mazzinghi Letizia De Chiara Francesco Guzzi Laura Lasagni Paola Romagnani Elena Lazzeri Source Type: research

Effectiveness and safety of Ustekinumab for the treatment of Crohn ’s disease in real-life experiences: a meta-analysis of observational studies
Volume 20, Issue 2, February 2020, Page 193-203 . (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - January 25, 2020 Category: Drugs & Pharmacology Authors: Fabio Salvatore Macaluso Marcello Maida Marco Ventimiglia Mario Cottone Ambrogio Orlando Source Type: research

In which patients the best efficacy of secukinumab? Update of a real-life analysis after 136 weeks of treatment with secukinumab in moderate-to-severe plaque psoriasis
Volume 20, Issue 2, February 2020, Page 173-182 . (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - January 25, 2020 Category: Drugs & Pharmacology Authors: Marco Galluzzo Simone D ’Adamio Dionisio Silvaggio Paolo Lombardo Luca Bianchi Marina Talamonti Source Type: research

Evolving primary and secondary endpoints in randomized controlled trials leading to approval of biologics and small molecules in IBD: an historical perspective
Volume 20, Issue 2, February 2020, Page 151-161 . (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - January 25, 2020 Category: Drugs & Pharmacology Authors: Patrick B. Allen Stefanos Bonovas Silvio Danese Laurent Peyrin-Biroulet Source Type: research

Rationale, discovery and clinical development of NEO-201
Volume 20, Issue 2, February 2020, Page 105-108 . (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - January 25, 2020 Category: Drugs & Pharmacology Authors: Philip M. Arlen Maria Pia Morelli Source Type: research

Efficacy of Tumour Necrosis Factor-alpha therapy in paediatric Crohn ’s disease patients with perianal lesions: a systematic review
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - January 24, 2020 Category: Drugs & Pharmacology Authors: Carla Carnovale Anna Maffioli Gloria Zaffaroni Faizan Mazhar Vera Battini Giulia Mosini Marco Pozzi Sonia Radice Emilio Clementi Piergiorgio Danelli Source Type: research

Bioengineering strategies for nephrologists: kidney was not built in a day
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - January 24, 2020 Category: Drugs & Pharmacology Authors: Anna Julie Peired Benedetta Mazzinghi Letizia De Chiara Francesco Guzzi Laura Lasagni Paola Romagnani Elena Lazzeri Source Type: research

Up-to-date surgery for ulcerative colitis in the era of biologics
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - January 23, 2020 Category: Drugs & Pharmacology Authors: Takayuki Yamamoto Michele Carvello Amy Lee Lightner Antonino Spinelli Paulo Gustavo Kotze Source Type: research

Vedolizumab and etrolizumab for ulcerative colitis: twins or simple cousins?
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - January 22, 2020 Category: Drugs & Pharmacology Authors: Ferdinando D ’Amico Silvio Danese Laurent Peyrin-Biroulet Source Type: research

Antibody therapies for multiple myeloma
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - January 22, 2020 Category: Drugs & Pharmacology Authors: Ioannis Ntanasis-Stathopoulos Maria Gavriatopoulou Evangelos Terpos Source Type: research

Anti-IL-4/IL-13 for the treatment of asthma: the story so far
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - January 21, 2020 Category: Drugs & Pharmacology Authors: Angela Moran Ian D Pavord Source Type: research

Prospects of biological and synthetic pharmacotherapies for glioblastoma
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - January 21, 2020 Category: Drugs & Pharmacology Authors: David B. Altshuler Padma Kadiyala Felipe J. Nu ñez Fernando M. Nu ñez Stephen Carney Mahmoud S. Alghamri Maria B. Garcia-Fabiani Antonela S. Asad Alejandro J. Nicola Candia Marianela Candolfi Joerg Lahann James J. Moon Anna Schwendeman Pedro R. Lowenste Source Type: research

Targeting the cutaneous lymphocyte antigen (CLA) in inflammatory and neoplastic skin conditions
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - January 21, 2020 Category: Drugs & Pharmacology Authors: Alvise Sernicola Irene Russo Micol Silic-Benussi Vincenzo Ciminale Mauro Alaibac Source Type: research

Evolving primary and secondary endpoints in randomized controlled trials leading to approval of biologics and small molecules in IBD: an historical perspective
Volume 20, Issue 2, February 2020, Page 151-161 . (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - January 21, 2020 Category: Drugs & Pharmacology Authors: Patrick B. Allen Stefanos Bonovas Silvio Danese Laurent Peyrin-Biroulet Source Type: research

Tumor localized agonistic anti-CD40 therapy and beyond
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - January 10, 2020 Category: Drugs & Pharmacology Authors: Mohamed Eltahir Helena Persson Sara Mangsbo Source Type: research

Histological healing: should it be considered as a new outcome for ulcerative colitis?
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - January 10, 2020 Category: Drugs & Pharmacology Authors: Arianna Dal Buono Giulia Roda Marjorie Argollo Laurent Peyrin-Biroulet Silvio Danese Source Type: research

Is there room for immunomodulators in ulcerative colitis?
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - December 31, 2019 Category: Drugs & Pharmacology Authors: Tarun Chhibba Christopher Ma Source Type: research

In which patients the best efficacy of secukinumab? Update of a real-life analysis after 136 weeks of treatment with secukinumab in moderate-to-severe plaque psoriasis
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - December 28, 2019 Category: Drugs & Pharmacology Authors: Marco Galluzzo Simone D ’Adamio Dionisio Silvaggio Paolo Lombardo Luca Bianchi Marina Talamonti Source Type: research

Effectiveness and safety of Ustekinumab for the treatment of Crohn ’s disease in real-life experiences: a meta-analysis of observational studies
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - December 27, 2019 Category: Drugs & Pharmacology Authors: Fabio Salvatore Macaluso Marcello Maida Marco Ventimiglia Mario Cottone Ambrogio Orlando Source Type: research

Rationale, discovery and clinical development of NEO-201
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - December 25, 2019 Category: Drugs & Pharmacology Authors: Philip M. Arlen Maria Pia Morelli Source Type: research

LBEC0101, an etanercept biosimilar for the treatment of rheumatoid arthritis
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - December 22, 2019 Category: Drugs & Pharmacology Authors: Yeong Wook Song Yong-Beom Park Jinseok Kim Source Type: research

Anti-MADCAM therapy for ulcerative colitis
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - December 19, 2019 Category: Drugs & Pharmacology Authors: Sherman Picardo Remo Panaccione Source Type: research

Therapeutic potential of mesenchymal stem/stromal cell-derived secretome and vesicles for lung injury and disease
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - December 19, 2019 Category: Drugs & Pharmacology Authors: Airan Liu Xiwen Zhang Hongli He Li Zhou Yoshifumi Naito Shinji Sugita Jae-Woo Lee Source Type: research